Antiphlogistic hydrogels based on the white lily
Authors:
Zuzana Vitková 1; Daniel Grančai 2; Mária Haladová 2; Petra Herdová 1; Mária Cupáková 3; Drahomíra Rauová 3
Authors place of work:
Univerzita Komenského Bratislava, Farmaceutická fakulta, Katedra galenickej farmácie
1; Univerzita Komenského Bratislava, Farmaceutická fakulta, Katedra farmakognózie a botaniky
2; Univerzita Komenského Bratislava, Farmaceutická fakulta, Toxikologické a antidopingové centrum
3
Published in the journal:
Čes. slov. Farm., 2011; 60, 189-192
Category:
Original Articles
Summary
The paper describes the formulation of hydrogels based on carbopol with an ethanol extract of the white lily with an anti-inflammatory effect. The active ingredients of the hydrogel were in the form of 60% and 80% ethanol extracts from the white lily and the ethanol lily extract supplied by Calendula, a. s. Nová Ľubovňa, Slovakia. Flow characteristics of the prepared hydrogels were evaluated by a rotational viscosimeter on the 2nd, 7th, 14th and 28th days after preparation. Based on the achieved results, the best flow characteristics were obtained from 1% carbopol hydrogel with a 2.4% concentration of 80% ethanol lily extract. According to the liberation of the active ingredients from the prepared hydrogels as well as the solitary ethanol extracts of the white lily, the content of extractive compounds was determined by the gravimetric method. The content was then colorimetrically standardized to the main flavonoid part – kempferol. Due to the highest content of kempferol and its optimal rheological properties, the hydrogel with 2.4% of 80%-ethanol extract of the white lily was evaluated as the most suitable one.
Key words:
hydrogel – carbopol – white lily – rheological parameters – liberation
Zdroje
1. Vachálková, A., Eisenreichová, E., Haladová, M., Mučaji, P., Jóžová, B., Novotný, L.: Potential carcinogenic and inhibitory activity of compounds isolated from Lilium candidum L. Neoplasma 2000; 47, 313–318.
2. Bezáková, L., Mučaji, P., Eisenreichová, E., Haladová, M., Pauliková, I., Obložinský, M.: Effect of different compounds from Lilium candidum L. on lipoxygenase activity. Acta Facult. Pharm. Univ. Comenianae 2004; 51, 45–50.
3. Mučaji, P., Haladová, M., Eisenreichová, E.: Stanovenie extraktívnych látok a vybraných sekundárnych metabolitov v Lilium candidum L. Farm. Obzor 2006; 75, 10–13.
4. Mučaji, P., Hudecová, D., Haladová, M., Eisenreichová, E.: Protikvasinková aktivita etanolových extraktov Lilium candidum L. Čes. slov. Farm. 2002; 51, 297–300.
5. Eisenreichová, E., Mašterová, I., Bučková, A., Haladová, M., Tomko, J.: Obsahové látky Lilium candidum L. Čes. slov. Farm. 1985; 34, 408–409.
6. Haladová, M., Eisenreichová, E., Mučaji, P., Buděšínský, M., Ubik, K.: Steroidal saponins from Lilium candidum L. Collect. Czech. Chem. Commun. 1998; 63, 205–210.
7. Mučaji, P., Haladová, M., Eisenreichová, E., Buděšínský, M., Ubik, K.: Jatropham 5-O-ß-D-glucopyranoside from Lilium candidum L. Collect. Czech. Chem. Commun. 1996; 61, 1662–1664.
8. Uhrín, D., Bučková, A., Eisenreichová, E., Haladová, M., Tomko, J.: Constituents of Lilium candidum L. Chem. Papers 1989; 43, 793–796.
9. Haladová, M., Eisenreichová, E., Bučková, A., Tomko, J., Uhrín, D., Ubik, K.: Dimeric pyrroline alkaloids from Lilium candidum L. Collect. Czech. Chem. Commun. 1991; 56, 436–438.
10. Chalabala, M., et al.: Liekové formy. 2.vyd. Martin: Osveta 1985; 360 s.
11. Lichnerová, I., Souadatou, D.: Tokové vlastnosti gélov Carbopolu 934. Farm. Obzor 1993; 62, 187.
12. Juránek, I., Suchý, V., Stará, D., Mašterová, I., Grančaiová, Z.: Antioxidative activity of hemoisoflavonoids from Muscari racemosum and cinnabari. Pharmazie 1993; 48, 310.
13. Brázdovičová, B., Vitková, Z., Grančaiová, K., Liščáková, A.: Vplyv exogénnych faktorov na reologické vlastnosti hydrogélov Carbopolu®940 s Bukofitom. Farm. Obzor 2008; 77, 211–214.
14. Vitková, Z., Herdová, P., Šubová, M., Šimunková, V.: Formulácia chlórhexidínu do hydrogélov. Čes. slov. Farm 2009; 58, 116–118.
Štítky
Pharmacy Clinical pharmacologyČlánok vyšiel v časopise
Czech and Slovak Pharmacy
2011 Číslo 4
Najčítanejšie v tomto čísle
- On the history of pharmaceutical industry in the Czech Lands. INTERPHARMA
- Antagonists of angiotensin AT1 receptors
- Clinical significance of cytochrome P450 genetic polymorphism – part II. Cytochrome P450 2C9
- Antiphlogistic hydrogels based on the white lily